We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Willis Towers Watson Plc | LSE:0Y4Q | London | Ordinary Share | IE00BDB6Q211 | WILLIS TOWERS WATSON ORD SHS |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 155.62 | 118 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Ins Agents,brokers & Service | 9.63B | 1.06B | 10.2889 | 22.51 | 23.74B |
TIDM0Y4Q
RNS Number : 0573I
BlackRock Group
30 March 2020
Ap19
FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION Name of person dealing BlackRock, Inc. (Note 1) Company dealt in Willis Towers Watson plc ======================== Class of relevant security US$0.000304635 ordinary to which the dealings shares being disclosed relate (Note 2) ======================== Date of dealing 27 March 2020 ======================== 2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3) Long Short Number (%) Number (%) =========== ======= =========== ====== (1) Relevant securities 11,912,355 (9.25%) 32 (0.00%) ==================== =================== (2) Derivatives (other than options) 108,436 (0.08%) 5,636 (0.00%) ==================== =================== (3) Options and agreements to purchase/sell 0 (0.00%) 79,300 (0.06%) ==================== =================== Total 12,020,791 (9.33%) 84,968 (0.06%) ==================== ===================
(b) Interests and short positions in relevant securities of the company, other than the class dealt
in (Note 3) Class of relevant security: Long Short Number (%) Number (%) ========= ====== =========== ====== (1) Relevant securities =================== ===================== (2) Derivatives (other than options) =================== ===================== (3) Options and agreements to purchase/sell =================== ===================== Total =================== =====================
Ap20
1. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of relevant securities Price per unit (Note 5) Purchase 1,100 USD 158.4164 ====================================== ==================== Purchase 49 USD 162.7550 ====================================== ==================== Purchase 224 USD 166.1584 ====================================== ==================== Purchase 3,642 USD 167.2100 ====================================== ==================== Purchase 85 USD 170.5000 ====================================== ==================== Sale 10 USD 165.7170 ====================================== ==================== Sale 39,120 USD 166.8512 ====================================== ==================== Sale 1,556 USD 167.2100 ====================================== ====================
Please note: there was also a Transfer In of 8,537 Shares
(b) Derivatives transactions (other than options transactions) Product Nature of transaction Number of relevant Price per name, (Note 6) securities unit e.g. CFD (Note 7) (Note 5) CFD Increasing Long 1,574 USD 159.3086 ===================== ================== ============ CFD Reducing Short 6 USD 167.2100 ===================== ================== ============ (c) Options transactions in respect of existing relevant securities (i) Writing, selling, purchasing or varying Product Writing, Number of Exercise Type, Expiry Option name, selling, securities price e.g. American, date money paid/received e.g. call purchasing, to which European per unit option varying the option etc. (Note 5) etc. relates (Note 7) (ii) Exercising Product name, Number of securities Exercise price e.g. call option per unit (Note 5)
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction Details Price per unit (Note 8) (if applicable) (Note 5) Stock on Loan 9,400 N/A ============== ==================== Return of Stock 27,109 N/A on Loan ============== ====================
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any
other person relating to the voting rights of any relevant securities under any option referred to on this
form or relating to the voting rights or future acquisition or disposal of any relevant securities to
which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 attached? (Note 9) YES Date of disclosure 30 March 2020 Contact name Jana Blumenstein ================ Telephone number +44 20 7743 3650 ================ If a connected EFM, name of offeree/offeror with which connected ================ If a connected EFM, state nature of connection (Note 10) ================
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1) Product Written, Number of relevant Exercise Type, e.g. Expiry name, or purchased securities price American, date e.g. call to which the (Note European option option or derivative 2) etc. relates Call Option Written 33,200 USD 208.0000 European 02/04/2020 ============== ====================== ============ ========== ========== Call Option Written 900 USD 220.0000 American 17/04/2020 ============== ====================== ============ ========== ========== Call Option Written 19,700 USD 170.0000 American 17/04/2020 ============== ====================== ============ ========== ========== Call Option Written 25,500 USD 215.0000 European 17/04/2020 ============== ====================== ============ ========== ==========
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be
given on this form. 2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosur e requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
ISEJMMMTMTJJBLM
(END) Dow Jones Newswires
March 30, 2020 10:20 ET (14:20 GMT)
1 Year Willis Towers Watson Chart |
1 Month Willis Towers Watson Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions